SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in mice. Sanchez-Martinez ZV, Alpuche-Lazcano SP, Stuible M, Akache B, et al. Vaccine 2024;42:126463.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sanchez-Martinez ZV, Alpuche-Lazcano SP, Stuible M, Akache B, et al. SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in mice. Vaccine 2024;42:126463.
PMID: 39481241